Global Health Forum Announced to Drive Innovation for an Equitable Healthcare Future
New York, NY, March 17, 2025 (GLOBE NEWSWIRE) -- A groundbreaking initiative, the Global Health Forum (GHF) has been launched with the mission to shape a more equitable and healthier future by fostering innovation, collaboration, and investment in the healthcare sector.
Spearheaded by Dr. Achintya Moulick ,CEO of CarePoint Health, Dr. Samin Sharma, Head of Cardiology at Mt. Sinai, and Mr. Sanat Chattopadhyay Executive Vice President, and President of Merck Manufacturing Division, this initiative is designed to make a transformative impact. Headquartered in Manhattan, NY and will soon establish offices in London, UK and Mumbai, India.
A strategic approach towards Global Healthcare Transformation
Non-Profit Wing: Dedicated to improving healthcare access for underprivileged communities in the India-US corridor, this entity will drive six key agendas (detailed at www.globalhealth-congress.org). The inaugural Global Congress will take place in the NY/NJ region in November 2025 and will bring together leading physicians, pharma and health-tech leaders, hospitals, and industry experts to drive actionable change. More details can be found at www.globalhealthcongress.com.Supporting Healthcare Innovation : Enabled through a proprietary digital platform, this entity 'Venture Vault' will bring together top industry leaders from diverse sectors to promote healthcare innovations, connect leaders across healthcare verticals, and fund and mentor high-growth, high-potential companies committed to advancing healthcare.
Leaders Speak: A Vision for Healthcare Innovation and Equity
Dr. Achintya Moulick, a career CEO and Cardiac Surgeon, emphasized the urgent need for a collaborative approach: "Healthcare innovation must be inclusive. Our initiative will bridge the gaps between research, technology, and accessibility, ensuring a healthier future for all—especially those who have been left behind."
Dr. Samin Sharma, Director of Interventional Cardiology at Mount Sinai Health System, highlighted the vision behind the for-profit wing:"By bringing together leaders from various industries, our digital platform will not only fund cutting-edge healthcare solutions but also mentor and scale ventures that can transform the way healthcare is delivered worldwide."
Mr. Sanat Chattopadhyay, Executive Vice President, and President of Merck Manufacturing, underscored the initiative's global potential:"This is more than just an initiative—it's a movement towards a sustainable and equitable healthcare system. Our Global Congress will serve as a catalyst for meaningful conversations and real-world solutions."
A Call to Action
With the Global Congress Conference in November and the investment platform launching soon, the Global Health Forum and Congress invites healthcare leaders, innovators, investors, and policymakers to join this movement.
For more information, visit:Non-Profit Initiative: www.globalhealth-congress.orgGlobal Health Congress Conference: www.globalhealthcongress.com
For media inquiries and partnerships, contact:Gautam BazazPhone:646.790.4600Email: gautam@globalhealth-congress.org303-5 th Avenue, Suite 1007New York, NY 10016
CONTACT: Gautam Bazaz gautam (at) globalhealth-congress.orgSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
TAB Bank Prescribes $2 Million Asset-Based Line of Credit for a Medical Supply Chain Financing and Logistics Company
OGDEN, Utah, June 04, 2025 (GLOBE NEWSWIRE) -- TAB Bank has provided a $2 million revolving asset-based line of credit for a Canadian medical supply chain financing and logistics company. The company opened a $2 million Certificate of Deposit (CD) at TAB Bank to serve as collateral on the loan. TAB Bank's high-yield CD rate, currently at a 4.15% Annual Percentage Yield (APY), is a primary reason the medical supply chain solution provider chose to work with TAB. This strategic move allows the company to earn a return on its deposit while simultaneously building its commercial borrowing profile. The company offers supply chain financing and logistics support tailored specifically for North American medical service providers purchasing from local and global manufacturers. It provides a data-driven approach to procurement, inventory and end-to-end supply chain management of essential medical commodities, such as surgical supplies and medical devices for healthcare providers. 'The medical supply chain solution provider's decision to utilize TAB Bank's high-yield CD as collateral is a smart, forward-thinking strategy,' said Ryan Gabriel, Vice President and Business Development Officer for the Pacific Northwest and Western Canada at TAB Bank. 'It also highlights one of TAB's key strengths—offering competitive deposit products that work hand-in-hand with our lending solutions to build value for our clients.' TAB Bank offers customized financial products to small and midsized businesses across a wide range of industries, like asset-based lending, equipment financing and working capital solutions. The bank's personalized service and bold financial solutions continue to attract clients across North America. About TAB BankAt TAB Bank, our mission is to unlock dreams with bold financial solutions that empower individuals and businesses nationwide. We are committed to making financial success accessible to everyone through our innovative banking products. Our dedication drives us to continuously improve, ensuring that we meet the evolving needs of our clients with excellence and agility. For over 25 years, we have remained steadfast in offering tailored, technology-enabled solutions designed to simplify and enhance the banking experience. For more information about how we can help you achieve your financial dreams, visit Contact Information:Trevor MorrisDirector of in to access your portfolio
Yahoo
an hour ago
- Yahoo
CRISPR Market Research and Competitive Landscape Report 2025 - Global Forecast to 2030: Rising Adoption in Research and Therapy Drives Growth with Thermo Fisher Scientific and Merck Leading
Growth is fueled by increased adoption in research and industry, advancements in CRISPR tools, and rising investments in biotechnology. Key applications include drug discovery and gene therapy, with pharmaceutical and biotech companies dominating the market. North America leads the sector, driven by innovative research and strong investment. Amidst this expansion, companies like Thermo Fisher Scientific and Merck KGaA emerge as market leaders, shaping the competitive landscape with new developments and collaborations. CRISPR Market Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "CRISPR Market by Offering [Product (Kits, Enzymes, Libraries), Service (gRNA Synthesis, Cell Line Development, Screening, Validation)], Application (Drug Discovery, Development, Agriculture) Competitive Landscape, Company Profiles -Global Forecast to 2030" has been added to offering. The global CRISPR market is set to expand from USD 3.21 billion in 2025 to USD 5.47 billion by 2030, registering a robust CAGR of 11.2% The report presents an analysis of market drivers, focusing on the rising demand for CRISPR-based therapies and ongoing technological advancements. It identifies key opportunities for CRISPR in areas such as vaccines and genetic disease treatments. A comprehensive evaluation of market shares and growth strategies of leading companies is included, along with an overview of challenges, particularly regulatory hurdles, that affect market progression. Growth is fueled by the technology's expanding use in research, clinical, and industrial applications, supported by increased investments in biotechnology R&D and the growing prevalence of genetic disorders. As CRISPR tools and delivery systems improve, and regulatory frameworks become more supportive, the integration of CRISPR into research and therapeutic pipelines accelerates. Leading companies include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, GenScript, Takara Bio, Creative Biogene, Fujian SunyBiotech, Caribou Biosciences, Lonza Group, Danaher Corporation, among others. Products Dominated the Market in 2024 The CRISPR market is divided into products and services. The products segment, which includes CRISPR kits & enzymes and CRISPR libraries, leads the market. These products are essential in academic, clinical, and industrial research for genome editing and therapeutic development. This segment's growth is driven by the demand for standardized and innovative CRISPR products. Drug Discovery & Development: A Fast-Growing Application Segment Within applications, drug discovery & development is the largest and fastest-growing segment, leveraging CRISPR to find gene-disease links and streamline drug functions. This reduces timelines and increases success probabilities. Pharmaceutical and biotechnology firms are pivotal in incorporating CRISPR for personalized medicine and functional genomics, further driving the technology's adoption. Pharmaceutical & Biotechnology Companies' Market Dominance in 2024 These companies led the CRISPR products market in 2024, thanks to increased investment in cell and gene therapies, and the need for precise genetic tools. Their financial strength allows them to implement advanced CRISPR technologies effectively, bolstering their market position. North America's Leadership in the CRISPR Market North America, with its prominent research institutions and substantial biotech investments, captured the largest CRISPR market share in 2024. The region's emphasis on medical research and personalized medicine offers it a competitive edge. European markets, especially in Germany, the UK, and France, are also seeing robust growth due to heightened R&D activity. Key Attributes: Report Attribute Details No. of Pages 267 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $3.21 Billion Forecasted Market Value (USD) by 2030 $5.47 Billion Compound Annual Growth Rate 11.2% Regions Covered Global Market Dynamics Drivers Growing Demand for Crispr-Based Gene Therapies Advancements in Crispr Technology Growing Government and Private Investments and Funding for Crispr Technology Restraints Technical Challenges Associated With Crispr Technology Opportunities Development of New Vaccines and Treatments for Genetic Diseases Expanding Industrial and Agricultural Applications of Crispr Challenges Regulatory Hurdles for Crispr Advancements Technology Analysis Key Technologies Crispr-Cas Systems Grna Design & Optimization High-Throughput Crispr Screening Complementary Technologies Synthetic Biology Single-Cell Genomics Next-Generation Sequencing Adjacent Technologies Stem Cell Engineering Synthetic Dna & Gene Synthesis Microfluidics Company Profiles Thermo Fisher Scientific Inc. Merck Kgaa Agilent Technologies, Inc. Genscript Revvity Lonza Danaher Corporation Takara Bio Inc. Creative Biogene Fujian Sunybiotech Co., Ltd. Editco Caribou Biosciences, Inc. Hera Biolabs Origene Technologies, Inc. Cellecta, Inc. Mammoth Biosciences, Inc. Applied Stemcell New England Biolabs Toolgen, Inc. Genecopoeia, Inc. Twist Bioscience Synthego Egenesis Inscripta, Inc. Precision Biosciences For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment CRISPR Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Saudi Arabia $485+ Mn Energy Drink Market Forecast & Opportunities, 2030F: Health Awareness Drive Expansion, Sustainable Packaging Gains Traction as Consumer Demand Rises
Opportunities in Saudi Arabia's energy drink market stem from rising health awareness, urbanization, and social media influence. As busy lifestyles elevate demand for energy-boosting drinks, increased disposable income and government support for fitness amplify market growth. Emphasizing sustainable packaging attracts eco-conscious consumers. Saudi Arabian Energy Drink Market Dublin, May 27, 2025 (GLOBE NEWSWIRE) -- The "Saudi Arabia Energy Drink Market by Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to Saudi Arabia Energy Drink Market was valued at USD 398.41 Million in 2024 and is projected to reach USD 486.11 Million by 2030, rising at a CAGR of 3.37% Market expansion is fueled by increased awareness of health and wellness, leading consumers to seek functional beverages that offer energy and mental alertness. As urbanization progresses and lifestyles grow busier, demand for portable, energy-boosting solutions continues to rise. The market also benefits from the influence of social media and digital campaigns that resonate strongly with younger demographics. A surge in disposable income is enabling greater consumer spending on premium and branded energy drinks. Furthermore, the government's backing of fitness culture and sports events has heightened interest in performance-enhancing beverages among active individuals. These combined dynamics are shaping a resilient and steadily growing market landscape across the Kingdom. Key Market Drivers: Rising Working Population Coupled with Their Hectic Schedules The expanding working population in Saudi Arabia, which accounts for approximately 73.2% of the total population as of 2024, is a key driver of energy drink consumption. As more individuals engage in full-time employment and juggle increasingly demanding routines, the need for quick energy-boosting options has grown. Energy drinks are increasingly seen as a practical solution for professionals in sectors such as healthcare, education, and corporate offices who seek enhanced focus and reduced fatigue throughout their workday. The rise of dual-income households and the growing participation of women in the workforce have further strengthened demand for convenient and functional beverages. Energy drinks have become integral to helping busy individuals sustain energy levels and maintain productivity in fast-paced environments, solidifying their role in daily routines. Key Market Challenges: Intense Competition Among Major Players The Saudi energy drink market faces heightened competitive pressures due to the presence of established international brands and emerging local players. Global giants like Red Bull and Monster compete alongside regional favorites such as Power Horse and Bison, creating a crowded marketplace. Private label and budget-friendly alternatives appeal to cost-conscious consumers, adding further complexity. Price competition and similar product offerings make it challenging for brands to achieve differentiation and retain customer loyalty. In addition, government regulations - such as restrictions on energy drink marketing and sponsorship - limit promotional opportunities and brand visibility, especially for foreign companies reliant on aggressive marketing. These dynamics compel manufacturers to innovate, adapt, and invest in strategic distribution to stay competitive and maintain market share. Key Market Trends: Increased Focus on Sustainable Packaging A growing trend in Saudi Arabia's energy drink market is the transition to sustainable packaging. Environmentally conscious consumers are driving demand for eco-friendly alternatives, encouraging manufacturers to adopt recyclable and reduced-plastic packaging formats. Research shows that a majority of consumers are more inclined to purchase products with environmentally responsible packaging. As a result, companies like Tetra Pak are introducing plant-based packaging and supporting local recycling initiatives to align with sustainability goals. This focus on green packaging not only meets consumer expectations but also supports the Kingdom's broader environmental and circular economy initiatives. Energy drink brands that prioritize sustainability are better positioned to win consumer trust and build long-term brand equity. Key Attributes: Report Attribute Details No. of Pages 82 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $398.41 Million Forecasted Market Value (USD) by 2030 $486.11 Million Compound Annual Growth Rate 3.3% Regions Covered Saudi Arabia Report Scope Key Players Profiled in this Saudi Arabia Energy Drink Market Report: PepsiCo, Inc. Monster Energy Company Taisho Pharmaceutical Holdings Co., Ltd Amway Corporation Nestle S.A. Coca-Cola HBC AG Monarch Beverages Hell Energy Celsius Zoa Energy, LLC Saudi Arabia Energy Drink Market, by Type: Organic Non-Organic Natural Saudi Arabia Energy Drink Market, by Target Consumers: Teenagers Adults Geriatric Population Saudi Arabia Energy Drink Market, by Distribution Channel: Store-Based Non-Store Based Saudi Arabia Energy Drink Market, by Region: Eastern Western Northern & Central Southern For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Saudi Arabian Energy Drink Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
